Evidence map›Paper›PMID 38737645›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2024

[

Pan Zhou, Zheng Li, Danni Li, Shuai Xue, Rou Li, Lan Zhang, Qingyun Bai, Xiao Li

Abstract read
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Chemical & biomedical imaging · 2026
    Article
  2. Review
  3. Article
  4. Radiotracers for Molecular Imaging of Angiotensin-Converting Enzyme 2.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pan ZhouSchool of Chemistry and Bioengineering, Yichun University Yichun 336000, Jiangxi, China.
Zheng LiShanghai Institute of Applied Physics, Chinese Academy of Sciences Shanghai 201800, China.
Danni LiDepartment of Nuclear Medicine, Shanghai Changhai Hospital Shanghai 200433, China.
Shuai XueSchool of Chemistry and Bioengineering, Yichun University Yichun 336000, Jiangxi, China.
Rou LiDepartment of Nuclear Medicine, Shanghai Changhai Hospital Shanghai 200433, China.
Lan ZhangShanghai Institute of Applied Physics, Chinese Academy of Sciences Shanghai 201800, China.
Qingyun BaiSchool of Chemistry and Bioengineering, Yichun University Yichun 336000, Jiangxi, China.
Xiao LiShanghai Institute of Applied Physics, Chinese Academy of Sciences Shanghai 201800, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a regulator in renin-angiotensin-aldosterone system, angiotensin-converting enzyme 2 (ACE2) closely correlated with tumor progression of pancreatic cancer, meantime, was easily affected by a variety of factors. [

Indexed as

[99mTc]Tc-cyc-DX600ACE2functional imagingpancreatic cancerrenin-angiotensin-aldosterone systemsingle photon emission computed tomography

Identifiers

PMID38737645
PMCPMC11087297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.